Core Laboratories NV Company Profile (NYSE:CLB)

About Core Laboratories NV

Core Laboratories NV logoCore Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company's services and products are directed toward enabling the Company's clients to improve reservoir performance and increase oil and gas recovery from their producing fields. The Company has over 70 offices in over 50 countries. The Company operates in three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and improve recovery of oil and gas from the Company's clients' reservoirs.

Industry, Sector and Symbol:
  • Sector: Oils/Energy
  • Industry: Oil & Gas Equipment & Services
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: CLB
  • CUSIP:
Key Metrics:
  • Previous Close: $104.76
  • 50 Day Moving Average: $113.25
  • 200 Day Moving Average: $117.75
  • 52-Week Range: $44,106,000.00 - $84.50
  • Trailing P/E Ratio: 55.58
  • Foreward P/E Ratio: 45.75
  • P/E Growth: 6.45
  • Market Cap: $4.62B
  • Outstanding Shares: 44,106,000
  • Beta: 1.56
  • Net Margins: 11.81%
  • Return on Equity: 344.55%
  • Return on Assets: 15.57%
  • Debt-to-Equity Ratio: 1.25%
  • Current Ratio: 2.03%
  • Quick Ratio: 1.61%
Additional Links:
Companies Related to Core Laboratories NV:

Analyst Ratings

Consensus Ratings for Core Laboratories NV (NYSE:CLB) (?)
Ratings Breakdown: 3 Sell Ratings, 10 Hold Ratings, 7 Buy Ratings
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $120.13 (14.67% upside)

Analysts' Ratings History for Core Laboratories NV (NYSE:CLB)
DateFirmActionRatingPrice TargetDetails
9/12/2016Citigroup Inc.Lower Price TargetNeutral$118.00 -> $116.00View Rating Details
9/1/2016Credit Suisse Group AGInitiated CoverageNeutral$115.00View Rating Details
7/12/2016JPMorgan Chase & Co.DowngradeNeutral -> UnderweightView Rating Details
6/13/2016KLR GroupReiterated RatingBuy$166.00 -> $180.00View Rating Details
4/23/2016Cowen and CompanyReiterated RatingHoldView Rating Details
4/23/2016Royal Bank Of CanadaReiterated RatingBuyView Rating Details
4/23/2016SimmonsReiterated RatingHold$105.00 -> $115.00View Rating Details
4/22/2016ABN AmroDowngradeBuy -> SellView Rating Details
4/22/2016StephensBoost Price TargetEqual Weight$89.00 -> $98.00View Rating Details
4/19/2016Morgan StanleyBoost Price TargetOverweight$120.00 -> $140.00View Rating Details
3/28/2016Howard WeilBoost Price Target$112.00View Rating Details
2/10/2016ING GroupLower Price TargetHold$125.00 -> $112.00View Rating Details
2/2/2016William BlairReiterated RatingOutperformView Rating Details
1/30/2016ScotiabankReiterated RatingSector Perform$117.00 -> $105.00View Rating Details
1/29/2016SunTrust Banks Inc.Lower Price TargetBuy$123.00 -> $109.00View Rating Details
1/29/2016Iberia CapitalLower Price TargetOutperform$140.00 -> $115.00View Rating Details
1/26/2016HSBCDowngradeHold -> ReduceView Rating Details
1/11/2016Oppenheimer Holdings Inc.Initiated CoverageMarket PerformView Rating Details
11/30/2015GuggenheimUpgradeNeutral -> Buy$135.00View Rating Details
9/30/2015Sterne Agee CRTLower Price TargetNeutral$113.00 -> $108.00View Rating Details
10/15/2014Evercore ISIInitiated CoverageBuy$151.00View Rating Details
(Data available from 9/25/2014 forward)


Earnings History for Core Laboratories NV (NYSE:CLB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/20/2016Q216$0.35$0.35$146.37 million$148.10 millionViewN/AView Earnings Details
4/20/2016Q116$0.37$0.37$161.24 million$153.65 millionViewN/AView Earnings Details
1/27/2016Q415$0.65$0.65$179.48 million$182.70 millionViewListenView Earnings Details
10/21/2015Q315$0.83$0.83$203.29 million$197.27 millionViewListenView Earnings Details
7/22/2015Q215$0.77$0.82$195.13 million$204.00 millionViewListenView Earnings Details
4/22/2015Q115$0.85$0.86$211.82 million$213.64 millionViewN/AView Earnings Details
1/28/2015Q414$1.54$1.54$280.18 million$278.60 millionViewN/AView Earnings Details
10/22/2014Q314$1.51$1.53$284.30 million$276.14 millionViewListenView Earnings Details
7/23/2014Q214$1.34$1.35$269.70 million$267.56 millionViewListenView Earnings Details
4/23/2014Q114$1.45$1.35$283.02 million$262.90 millionViewListenView Earnings Details
1/30/2014Q413$1.40$1.43$278.55 million$276.30 millionViewListenView Earnings Details
10/17/2013Q313$1.34$1.36$267.21 million$273.16 millionViewN/AView Earnings Details
7/17/2013Q2 2013$1.31$1.32$267.24 million$263.14 millionViewListenView Earnings Details
4/17/2013Q1 2013$1.15$1.22$260.90 million$260.90 millionViewListenView Earnings Details
1/30/2013Q4 2012$1.13$1.17$246.49 million$254.46 millionViewListenView Earnings Details
10/17/2012$1.10$1.13ViewN/AView Earnings Details
7/18/2012$1.16$1.16ViewN/AView Earnings Details
4/18/2012$1.07$1.06ViewN/AView Earnings Details
2/1/2012$1.08$1.09ViewN/AView Earnings Details
10/19/2011$0.99$0.93ViewN/AView Earnings Details
4/19/2011$0.75$0.77ViewN/AView Earnings Details
2/9/2011$0.81$0.84ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Core Laboratories NV (NYSE:CLB)
Current Year EPS Consensus Estimate: $1.56 EPS
Next Year EPS Consensus Estimate: $2.29 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166$0.35$0.75$0.53
Q2 20163$0.27$0.72$0.45
Q3 20163$0.28$0.77$0.48
Q4 20163$0.32$0.76$0.49
Q1 20172$0.40$0.81$0.61
Q2 20172$0.40$0.88$0.64
Q3 20172$0.43$0.97$0.70
Q4 20172$0.43$1.03$0.73
(Data provided by Zacks Investment Research)


Current Dividend Information for Core Laboratories NV (NYSE:CLB)
Annual Dividend:$2.20
Dividend Yield:2.10%
Dividend Growth:25.20% (3 Year Average)
Payout Ratio:117.65% (Based on Trailing 12 Months of Earnings)
141.03% (Based on Current Year Consensus EPS Estimate)
96.07% (Based on Next Year Consensus EPS Estimate)
Track Record:6 Years of Consecutive Dividend Growth

Dividend History for Core Laboratories NV (NYSE:CLB)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Core Laboratories NV (NYSE:CLB)
Insider Ownership Percentage: 1.00%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/2/2016Jan Willem SodderlandDirectorBuy300$93.90$28,170.00View SEC Filing  
5/12/2015Michael C KearneyDirectorSell1,000$128.52$128,520.00View SEC Filing  
11/17/2014Mark F ElvigVPSell1,000$138.03$138,030.00View SEC Filing  
7/28/2014Richard L BergmarkCFOBuy7,000$147.31$1,031,170.00View SEC Filing  
3/7/2014Michael KearneyDirectorSell2,000$193.00$386,000.00View SEC Filing  
2/14/2014Mark ElvigVPSell1,500$186.64$279,960.00View SEC Filing  
10/21/2013Monty L DavisCOOSell5,704$197.33$1,125,570.32View SEC Filing  
8/7/2013Richard BergmarkCFOSell20,000$149.58$2,991,600.00View SEC Filing  
7/25/2013Charles Brigham MillerCAOSell11,648$147.81$1,721,690.88View SEC Filing  
7/25/2013Monty L DavisCOOSell5,948$149.12$886,965.76View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Core Laboratories NV (NYSE:CLB)
DateHeadline logoCore Laboratories N.V. (NYSE:CLB) Had $22.494 In Cash And Short-Term Investments (NYSE:CLB) - September 24 at 4:05 PM logoCore Laboratories NV (NYSE:CLB) Had $22.494 In Cash And Short-Term Investments - Stocks Daily (NYSE:CLB) - September 24 at 8:29 AM
News IconCore Laboratories PT Lowered to $116.00 (CLB) - Petro Global News 24 (NYSE:CLB) - September 21 at 4:53 PM logoCore Lab Presents At Johnson Rice Energy Conference - PR Newswire (press release) (NYSE:CLB) - September 21 at 4:53 PM logoCORE LABORATORIES N V Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NYSE:CLB) - September 21 at 8:17 AM logoCore Lab Presents At Johnson Rice Energy Conference (NYSE:CLB) - September 21 at 8:17 AM logoHow SPN’s Current Valuation Compares to Its Peers’ (NYSE:CLB) - September 21 at 8:17 AM logoBullish Target For Core Laboratories N.V. (NYSE:CLB) At $150 - Investor Newswire (NYSE:CLB) - September 19 at 5:01 PM
News IconAnalysts Take Aim At This Stock's Earnings Estimates: Core Laboratories N.V. (NYSE:CLB) - Frisco Fastball (NYSE:CLB) - September 19 at 5:01 PM logoCore Laboratories N.V. (NYSE:CLB) Held $22.494 In Cash And Short-Term Investments (NYSE:CLB) - September 16 at 4:07 PM logoCore Laboratories N.V. Common S (CLB) - Citigroup Holds Rating And Sets New Price Target - Finance Daily (NYSE:CLB) - September 12 at 4:06 PM logoCore Laboratories NV (NYSE:CLB) CFF Stands At $-180.302 Millions - Stocks Daily (NYSE:CLB) - September 10 at 8:55 AM logoETF’s with exposure to Core Laboratories NV : September 9, 2016 (NYSE:CLB) - September 9 at 4:07 PM
News IconCore Laboratories N.V. (NYSE:CLB) From The Analysts Point of View - National Daily Press (NYSE:CLB) - September 9 at 9:04 AM logoCramer: Keep Calm About Apache and Invest On (NYSE:CLB) - September 9 at 9:04 AM logoThe Best Oil Stock You Can Buy (NYSE:CLB) - September 4 at 8:51 AM logoCoverage initiated on Core Labs by Credit Suisse (NYSE:CLB) - September 1 at 4:10 PM logoCredit Suisse Likes Core Laboratories Better As A Company Than As A Stock (NYSE:CLB) - September 1 at 11:40 AM logoShares of CLB Now Oversold (NYSE:CLB) - September 1 at 11:40 AM logoCore Laboratories N.V. (NYSE:CLB) Gets 0 Recommendations To Sell - Investor Newswire (NYSE:CLB) - August 25 at 4:17 PM logoCore Laboratories NV (NYSE:CLB) Cash and Short – Term Investments Is Reported At $22.494 Millions - Stocks Daily (NYSE:CLB) - August 20 at 7:58 AM
News IconWal-Mart records biggest same-store sales increase in four years - Petro Global News 24 (NYSE:CLB) - August 19 at 11:36 AM
News IconRetail & Analyst Ratings Forecasts on Core Laboratories N.V. (NYSE:CLB) - Post News (NYSE:CLB) - August 18 at 9:32 PM logoWill Core Laboratories N.V. (NYSE:CLB) Hit $150 Price Target? - Investor Newswire (NYSE:CLB) - August 18 at 9:32 PM logoWill Core Laboratories’ Strategies Improve Returns? (NYSE:CLB) - August 17 at 4:22 PM logoHow Volatile Is Core Laboratories Now? (NYSE:CLB) - August 17 at 10:59 AM logoReturns of Oilfield Services Stocks with High Implied Volatility (NYSE:CLB) - August 17 at 10:59 AM logo3 Oil Stocks to Buy in August (NYSE:CLB) - August 16 at 1:53 PM logoCore Laboratories’ Short Interest Is Increasing, but What Will That Mean? (NYSE:CLB) - August 16 at 9:17 AM logoIs Core Laboratories Overvalued at Current Levels? (NYSE:CLB) - August 15 at 11:30 AM logoIs Core Laboratories Currently Overvalued versus Peers? (NYSE:CLB) - August 15 at 11:30 AM logoWhat Are Core Laboratories’ Plans for Its Free Cash Flow? (NYSE:CLB) - August 12 at 11:38 AM logoIs Core Laboratories Planning a Share Buyback? (NYSE:CLB) - August 12 at 11:38 AM logoHow Much Debt Has Core Laboratories Reduced in 1H16? (NYSE:CLB) - August 11 at 11:32 AM logoWill Rig Count Affect Core Laboratories in 3Q16? (NYSE:CLB) - August 10 at 4:19 PM logoCore Laboratories N.V. Common S (CLB) Position Increased by Kayne Anderson Rudnick Investment Management ... - Finance Daily (NYSE:CLB) - August 9 at 10:40 PM logoIs Core Laboratories' Share Price Still Bullish? - Market Realist (NYSE:CLB) - August 9 at 5:14 PM logoWhat’s the Correlation between Core Laboratories’ Stock and Crude Oil? (NYSE:CLB) - August 9 at 5:14 PM logoCore Laboratories NV (NYSE:CLB) Quarterly Dividend At $-46.837 Millions - Stocks Daily (NYSE:CLB) - August 6 at 4:40 PM logoCitigroup Maintains Core Laboratories N.V. to Neutral with Price Target $118.00 - Trade Calls (NYSE:CLB) - August 2 at 9:02 AM logoRevenue Update on Core Laboratories N.V.(NYSE:CLB) - Trade Calls (NYSE:CLB) - July 29 at 8:04 AM logoCan Shares Of Core Laboratories N.V. (NYSE:CLB) Hit $150? - Investor Newswire (NYSE:CLB) - July 28 at 5:19 PM logoCORE LABORATORIES N V Financials (NYSE:CLB) - July 28 at 1:04 PM logoETF’s with exposure to Core Laboratories NV : July 26, 2016 (NYSE:CLB) - July 26 at 12:44 PM logoIs This The News Oil Investors Have Been Waiting For? (NYSE:CLB) - July 24 at 7:00 AM
News IconEarnings Roundup: Colfax Corporation (NYSE:CFX), Core Laboratories N.V. (NYSE:CLB), Valley National Bancorp ... - Engelwood Daily (NYSE:CLB) - July 23 at 8:31 AM
News IconShares Stumbling of Late: Core Laboratories NV (NYSE:CLB) - TGP (NYSE:CLB) - July 23 at 8:31 AM logoCORE LABORATORIES N V Files SEC form 10-Q, Quarterly Report (NYSE:CLB) - July 22 at 4:08 PM logoCore Laboratories NV :CLB-US: Earnings Analysis: Q2, 2016 By the Numbers : July 22, 2016 (NYSE:CLB) - July 22 at 12:33 PM logoIs $150 Price Target Attainable For Core Laboratories N.V. (NYSE:CLB)? - Investor Newswire (NYSE:CLB) - July 22 at 11:57 AM


Core Laboratories NV (NYSE:CLB) Chart for Sunday, September, 25, 2016

Last Updated on 9/25/2016 by Staff